Clinical Trials Logo

Soreness, Muscle clinical trials

View clinical trials related to Soreness, Muscle.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06122038 Completed - Inflammation Clinical Trials

Impact of Powdered Tart Cherries on Recovery From Repeated Sprints

TCR
Start date: April 25, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate changes in force and power production, soreness, inflammation, and oxidative stress after repeated sprinting activity and powdered tart cherry ingestion in trained males and females.

NCT ID: NCT04695548 Completed - Clinical trials for Trigger Point Pain, Myofascial

Physiotherapy in the Reduction of Post-needling Soreness

Start date: February 23, 2021
Phase: N/A
Study type: Interventional

Dry needling is a minimally invasive technique which generates good results and neuromuscular benefits. Its application involves a highly prevalent effect called post-needling soreness. It is defined as a residual pain, located in the incision area, with a self-limiting period of 24-72 hours, as a result of a physiological process generated by the technique. So far, different clinical trials have been carried out to measure the effectiveness of several techniques for reducing post-needling soreness, reaching positive results. However, no studies have been found with the aim of distinguish which method is more effective for this goal; therefore, it is clear the need to continue investigating on the subject and comparing these techniques among them.

NCT ID: NCT04230226 Completed - Clinical trials for Performance Enhancing Product Use

Acute Study on Muscle Soreness, Damage, and Performance

Start date: January 21, 2020
Phase: N/A
Study type: Interventional

The acute study will evaluate pre- and post-exercise ingestion of a multi-ingredient supplement in a randomized, double-blind, placebo-controlled, crossover design. Participants will complete one enrollment visit, in which they will sign a consent form and complete a health history questionnaire. Participants will complete two interventions, with three visits each (6 visits total), in which a treatment beverage (pre/post supplement, or non-caloric placebo) will be consumed within 30 minutes prior to exercise and within 15 minutes post-exercise, in random order. Total time from enrollment to completion will be at least 14 days. Testing visits will be separated by a minimum of 7 days of rest to allow for recovery and washout, based on a half-life of ≤8 hours for all ingredients present in the supplement.